Market Overview:
The global ampicillin API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ampicillin API due to its various applications in the pharmaceutical industry. The purity above 99% segment is expected to grow at a higher CAGR than other segments during the forecast period, owing to its high demand from major markets such as North America and Europe. In terms of application, tablets are expected to account for the largest share of the global ampicillin API market in 2018, followed by capsules and injections.
Product Definition:
Ampicillin is a penicillin antibiotic that fights bacteria in the body. Ampicillin is used to treat many different types of infections caused by bacteria, such as pneumonia, bronchitis, urinary tract infections, and gonorrhea. It is also used to treat ear infections and Salmonella infection.
Purity Abrove 99%:
Purity Abrove 99% is a type of Ampicillin antibiotic which is used in the treatment of bacterial infections. It has a broad spectrum of antimicrobial activity and excellent antibacterial resistance. The product was developed by E.I DuPont de Nemours & Co, it's called as “Ampicillin” or “DuPont Amp” after company that commercialized it globally till date.
Purity 99%:
Ampicillin is a penicillin based antibiotic used to treat bacterial infections. Penicillins were the first antibiotics developed and they are still among the most commonly used antibiotics today. Ampicillin is one of the most common brands of penicillins produced by Pfizer, Inc. It was discovered in 1928 and commercialized in 1929 by Eli Lilly & Co., who obtained US patent 2,068,879 for it on November 8th, 1929.
Application Insights:
In terms of application, the global market is categorized into tablets, capsules, injection and others. The other applications include powder for oral solution and topical cream. Ampicillin injection is expected to be the major application segment over the forecast period owing to its ability to treat a wide range of infections caused by bacteria including E. coli., staphylococcus aureus., salmonella typhimurium., klebsiella pneumoniae., Escherichia coli O157:H7 and many more.
The use of ampicillin injections has been declining in recent years due largely to extensive usage as an antibiotic in oral tablets & capsules for treatment purposes owing largely to rising resistance against it across various bacterial species especially among gram-positive bacteria such as Staphylococcus Aureus which accounts for approximately 80% of all drug resistant cases worldwide accordingto CDC data published in 2016.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. High adoption of ampicillin and other antibiotics for livestock production coupled with increasing awareness regarding antibiotic-resistant infections are some of the factors responsible for this dominance.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising demand from countries such as China, India, South Korea, Japan and Australia. Increasing prevalence of infectious diseases due to lack of hygiene and poor living conditions is also one factor driving regional market growth.
Growth Factors:
- Increasing demand for ampicillin API in the treatment of various infections caused by bacteria
- Rising prevalence of infectious diseases and growing awareness about the benefits of ampicillin API therapy among patients and healthcare professionals
- Technological advancements in the manufacturing process of ampicillin API that would help to reduce its production cost
- Growing number of generic manufacturers for ampicillin API worldwide that would lead to increased availability and affordability
- increasing research on new applications for ampicillin API that would open up new market opportunities
Scope Of The Report
Report Attributes
Report Details
Report Title
Ampicillin API Market Research Report
By Type
Purity Abrove 99%, Purity 99%
By Application
Tablets, Capsules, Injection, Others
By Companies
Otto Brandes GmbH, Novartis, JSN Chemical, ACS Dobfar, Nanjing Dorra Pharmaceutical Technology, Reyoung Pharmaceutical, Hangzhou Think Chemical, Penam Laboratories, Parabolicdrugs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
198
Number of Tables & Figures
139
Customization Available
Yes, the report can be customized as per your need.
Global Ampicillin API Market Report Segments:
The global Ampicillin API market is segmented on the basis of:
Types
Purity Abrove 99%, Purity 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablets, Capsules, Injection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Otto Brandes GmbH
- Novartis
- JSN Chemical
- ACS Dobfar
- Nanjing Dorra Pharmaceutical Technology
- Reyoung Pharmaceutical
- Hangzhou Think Chemical
- Penam Laboratories
- Parabolicdrugs
Highlights of The Ampicillin API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Abrove 99%
- Purity 99%
- By Application:
- Tablets
- Capsules
- Injection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ampicillin API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ampicillin API is a form of ampicillin that has been chemically modified so it can be absorbed through the skin. This makes it easier for doctors to give patients the drug intravenously, which is often the most effective way to treat infections.
Some of the key players operating in the ampicillin api market are Otto Brandes GmbH, Novartis, JSN Chemical, ACS Dobfar, Nanjing Dorra Pharmaceutical Technology, Reyoung Pharmaceutical, Hangzhou Think Chemical, Penam Laboratories, Parabolicdrugs.
The ampicillin api market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ampicillin API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ampicillin API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ampicillin API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ampicillin API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ampicillin API Market Size & Forecast, 2020-2028
4.5.1 Ampicillin API Market Size and Y-o-Y Growth
4.5.2 Ampicillin API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity Abrove 99%
5.2.2 Purity 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Injection
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ampicillin API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ampicillin API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity Abrove 99%
9.6.2 Purity 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tablets
9.10.2 Capsules
9.10.3 Injection
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity Abrove 99%
10.6.2 Purity 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tablets
10.10.2 Capsules
10.10.3 Injection
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity Abrove 99%
11.6.2 Purity 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tablets
11.10.2 Capsules
11.10.3 Injection
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity Abrove 99%
12.6.2 Purity 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tablets
12.10.2 Capsules
12.10.3 Injection
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity Abrove 99%
13.6.2 Purity 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tablets
13.10.2 Capsules
13.10.3 Injection
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ampicillin API Market: Competitive Dashboard
14.2 Global Ampicillin API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Otto Brandes GmbH
14.3.2 Novartis
14.3.3 JSN Chemical
14.3.4 ACS Dobfar
14.3.5 Nanjing Dorra Pharmaceutical Technology
14.3.6 Reyoung Pharmaceutical
14.3.7 Hangzhou Think Chemical
14.3.8 Penam Laboratories
14.3.9 Parabolicdrugs
